Highest Rated Comments


SSA_Sec_18194 karma

I've heard so much about this in DC and I'd love to hear your opinion: How big a blow the decision by Congress to increase the discount provided by manufacturers of brand-name drugs in the Pat D coverage gap from 50 percent to 70 percent? Did you see you change of activity after that? Does industry think they can roll that back?

SSA_Sec_18191 karma

Thanks for the reply! I'll definitely listen to that. Love/appreciate all your work!